Campus News

November 15, 2010
UCSF researchers have for the first time shown that an external optical pacemaker can be used in a vertebrate to control its heart rate.
November 04, 2010
UCSF global health experts have outlined a new strategy and action plan to help countries eliminate malaria and bring the world closer to global eradication of the deadly disease.
November 03, 2010
UCSF Nobel laureate Elizabeth Blackburn, PhD, and researcher Elissa Epel, PhD, are co-authors with UC Davis scientists of a paper showing that the positive psychological changes that occur during meditation training are associated with greater activity of the enzyme telomerase.
October 22, 2010
UCSF scientists have received two grants from the California Institute for Regenerative Medicine to refine their human embryonic stem cell-based strategies for treating neurological diseases and liver failure.
September 24, 2010
Diabetes research is on the cusp of new advances in treatment options and in understanding the underlying causes of both type 1 and type 2 diabetes. Among those are potential treatments using stem cells to regenerate a patient’s ability to produce insulin, as well as upcoming clinical trials of a vaccine that potentially could prevent type 1 diabetes.
September 23, 2010
The UCSF Diabetes Center will celebrate a decade of advancing translational research in diabetes on Friday, with a scientific symposium featuring the nation’s leaders in diabetes research and care.
August 30, 2010
UCSF is co-sponsoring a symposium on September 27 and 28 to provide scientists and physicians with the “nuts and bolts” of translating stem cell science into cell-based products for clinical trials.
July 29, 2010
Frank McCormick, director of the UCSF Helen Diller Family Comprehensive Cancer Center, is the recipient of the 2010 American Society of Clinical Oncology's Science of Oncology Award and Lecture.
July 19, 2010
With innovation as the watchword, a biotech spinoff from the UCSF School of Pharmacy announced a $40 million Series A round of investment last week – hailed by an investor as “one of the largest first rounds of financing in some time.”
May 19, 2010
Researchers have identified how a normal response to infection, one that usually serves to limit the amount of inflammation, actually contributes to disease progression and viral persistence in HIV-infected patients.

Pages